Blood tests for immunogenicity carried out among elderly volunteers turned out to be similar to those that were
If they have data that shows thatThe vaccine generates good immunity in the over 55 age group, and it [the use of the vaccine] is also accompanied by a good response in even older people, then I think this is a promising sign.
Jonathan Ball, professor of virology at the University of Nottingham
According to the publication, the most problematic factorWhen a vaccine is invented, age is a factor. Older patients have weakened immune systems, which may cause the vaccine to be ineffective for them.
Final results of the third stagevaccine trials will emerge once all the data for this age group has been analyzed. The FT notes that the results of a blood test from older study participants will soon be published in a medical journal.
The third phase of trials of the AstraZeneca vaccine is underway in the UK, Brazil, India, South Africa, Japan and is due to start again in the US soon.
Read also
Scientists have figured out exactly how heat stress damages sperm
The annual mission in the Arctic has ended and the data are disappointing. What awaits humanity?
On day 3 of illness, most COVID-19 patients lose their sense of smell and often suffer from a runny nose